Section

Solid Q2 Results Help CVS Health (CVS) Defy Market Rout

one year ago Market forbes
A comfortable top and bottom-line beat keeps the healthcare giant on pace to produce a juicy $13 billion in operating cash flow in 2023. Read more at: forbes

Tags : CVS CVS Health healthcare undervalued stocks inflation medicare Medicare Advantage pharmacy prescription volumes drug mix

Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Bollywood charcha does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.

You May Also Like